Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-288082
Filing Date
2015-08-12
Accepted
2015-08-12 16:06:16
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d948397d10q.htm 10-Q 536984
2 EX-10.1 d948397dex101.htm EX-10.1 114708
3 EX-10.2 d948397dex102.htm EX-10.2 475639
4 EX-31.1 d948397dex311.htm EX-31.1 8384
5 EX-31.2 d948397dex312.htm EX-31.2 8384
6 EX-32.1 d948397dex321.htm EX-32.1 5817
  Complete submission text file 0001193125-15-288082.txt   2631651

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ardx-20150630.xml EX-101.INS 267416
8 XBRL TAXONOMY EXTENSION SCHEMA ardx-20150630.xsd EX-101.SCH 22390
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ardx-20150630_cal.xml EX-101.CAL 39892
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ardx-20150630_def.xml EX-101.DEF 56027
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ardx-20150630_lab.xml EX-101.LAB 197936
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ardx-20150630_pre.xml EX-101.PRE 131644
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 151047074
SIC: 2834 Pharmaceutical Preparations